+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Surgical Incision Closures Market by Product Type, End User, Application, Indication, Wound Type - Global Forecast to 2030- Product Image
Surgical Incision Closures Market by Product Type, End User, Application, Indication, Wound Type - Global Forecast to 2030- Product Image
Sale

Surgical Incision Closures Market by Product Type, End User, Application, Indication, Wound Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889351
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Surgical Incision Closures Market grew from USD 16.74 billion in 2024 to USD 17.94 billion in 2025. It is expected to continue growing at a CAGR of 6.86%, reaching USD 24.93 billion by 2030.

Driving Innovation in Surgical Incision Closure Technologies

The field of surgical incision closure stands at the intersection of clinical necessity and technological ingenuity. As the volume of surgical procedures continues to rise globally, driven by demographic shifts and broader access to healthcare, the demand for reliable, efficient and patient-friendly closure methods has never been greater.

This report introduces the core trends and challenges defining the modern closure landscape. From the evolution of advanced hemostatic agents to the refinement of staples, sutures and novel tissue adhesives, the market is witnessing a surge in innovation that promises to enhance patient outcomes, reduce procedure times and optimize postoperative recovery.

Against this backdrop, stakeholders must navigate complex regulatory environments, shifting reimbursement policies and intensifying competition. This executive summary distills key insights on industry dynamics, emerging applications and strategic imperatives, offering decision-makers a clear perspective on where value is being created and how to capitalize on growth vectors over the coming years.

Embracing Disruptive Trends Transforming the Field

A convergence of technological breakthroughs and clinical demand is reshaping the surgical incision closure ecosystem. Minimally invasive approaches are prompting the development of devices that facilitate precision closure through smaller access points, while the integration of smart materials is unlocking capabilities such as bioresorbable adhesives with controlled degradation profiles.

At the same time, digital surgery platforms are enhancing the precision of staple deployment and suture placement, accelerating procedural speed and consistency. Advanced hemostatic agents, including absorbable gelatin sponges and thrombin formulations, are increasingly tailored for specific clinical scenarios, reducing intraoperative bleeding risks and enhancing visibility for surgeons.

Moreover, evolving reimbursement frameworks are incentivizing value-based solutions that demonstrate clear clinical and economic benefits. Collaborative partnerships between device manufacturers, healthcare providers and research institutions are fueling co-development of next-generation technologies. As regulatory bodies adapt to these innovations, the pace of product approvals is accelerating, creating an environment ripe for disruptive entrants and established players alike to redefine standards of care.

Assessing the Ripple Effects of 2025 US Tariff Measures

The implementation of new tariff measures in 2025 has introduced cost considerations that ripple throughout the surgical incision closure supply chain. Import duties on medical devices and raw materials have driven up baseline expenses for staples, sutures and tissue adhesives, prompting manufacturers to reassess sourcing strategies and regional manufacturing footprints.

Consequently, some producers have accelerated investments in domestic production capabilities to mitigate exposure to tariff volatility. While this strategic shift supports supply chain resilience, initial capital outlays and facility certification processes have temporarily strained operational budgets.

Healthcare institutions, facing heightened procurement costs, are demanding stronger value propositions, emphasizing total cost of care rather than unit pricing alone. This dynamic has intensified negotiations between providers and suppliers, with bundled purchasing agreements and outcome-based contracts emerging as key tools to balance quality imperatives against economic pressures.

Looking ahead, the tariff environment is likely to remain a focal point for supply chain optimization efforts. Companies that can demonstrate adaptability through diversified manufacturing, agile logistics and robust cost management will be best positioned to thrive in the face of evolving trade policies.

Unveiling Deep Market Segmentation Dynamics

An in-depth examination of the market reveals nuanced variations across product offerings, end-user settings, applications, indications and wound typologies. The spectrum of hemostatic solutions comprises absorbable gelatin sponges, oxidized regenerated cellulose and thrombin-based formulations, each engineered to address distinct bleeding profiles. The staples category bifurcates into manual devices favored for simple wound approximation and powered systems designed to streamline high-volume procedures. Within sutures, absorbable strands such as poliglecaprone, polydioxanone and polyglycolic acid co-exist alongside nonabsorbable materials including nylon, polypropylene and silk, reflecting surgeon preferences for tissue compatibility and tensile strength. Tissue adhesives further diversify the product landscape, spanning cyanoacrylate variants, fibrin-based sealants and polyethylene glycol compounds.

The settings in which these innovations are deployed range from ambulatory surgical centers to in-home care environments, with clinics that cater to multi-specialty procedures and those dedicated to single-specialty practices. Hospitals, both in the private and public sectors, remain pivotal, often serving as the proving ground for advanced closure techniques. Clinicians distinguish between external and internal applications, adapting selection criteria based on anatomical location and healing objectives.

Clinical indications extend across cardiovascular operations, general surgery, gynecological interventions, neurosurgical procedures, orthopedic reconstructions and pediatric cases. Each indication imposes unique demands on closure strategies, from hemostatic efficacy in cardiac surgery to minimal scarring priorities in pediatric patients. Wound classification further refines decision-making, as clean, clean contaminated, contaminated and dirty wound types each dictate appropriate closure protocols and preventive measures against infection.

Exploring Regional Variations Shaping Surgical Closure Demand

Geographic patterns reveal distinct regional drivers and adoption curves that are reshaping the global incision closure market. In the Americas, an aging population alongside robust reimbursement structures has catalyzed demand for both traditional and novel closure products. Private and public hospitals are leading procurement trends, while ambulatory surgical centers continue to capitalize on outpatient innovations.

Across Europe, Middle East & Africa, regulatory harmonization in Western Europe contrasts with emerging investment in high-growth Middle Eastern markets and nascent infrastructure in parts of Africa. Stakeholders navigating this region must balance stringent clinical standards with diverse economic environments, tailoring their go-to-market approaches to local requirements.

The Asia-Pacific region exhibits one of the fastest growth trajectories, fueled by expanding healthcare access in countries such as China and India, where government initiatives drive surgical volume increases. Japan’s advanced healthcare ecosystem underscores rapid adoption of cutting-edge adhesives and powered staples, while Southeast Asian markets present opportunities for scaled entry through strategic partnerships and localized manufacturing.

These regional insights underscore the importance of adaptive strategies that align product portfolios with local regulatory landscapes, reimbursement schemas and evolving clinical practices across the Americas, Europe, Middle East & Africa and Asia-Pacific.

Spotlight on Leading Companies Pioneering Incision Solutions

A competitive analysis highlights how leading companies are pursuing distinct pathways to sustain growth and outpace peers. Some manufacturers are focusing on acquisitions that complement existing portfolios, integrating specialized hemostatic agents or reinforcing their suture offerings through targeted buyouts. Others are investing heavily in internal R&D, collaborating with academic centers to co-develop biomaterials that offer improved biocompatibility and tailored degradation profiles.

Strategic alliances have emerged as a key tactic, allowing device makers to leverage each other’s distribution networks and regulatory expertise to accelerate market entry across geographies. Innovation pipelines are particularly robust among firms prioritizing digital integration, where sensor-enabled staples and AI-driven application guidance are poised to redefine procedural accuracy.

Meanwhile, mid-sized and niche players are distinguishing themselves through agile manufacturing and rapid iteration cycles, bringing incremental improvements to adhesive formulations and suture coatings with antimicrobial properties. Across the spectrum, successful companies are demonstrating a disciplined approach to portfolio management, balancing flagship product launches with initiatives to optimize legacy lines and address cost pressures.

Strategic Imperatives for Industry Stakeholders to Accelerate Growth

To excel in the competitive surgical incision closure arena, industry leaders must pursue a multifaceted strategy. First, accelerating investment in next-generation biomaterials will be critical to meet growing demand for patient-centric, resorbable adhesives and smart hemostats. By prioritizing R&D collaborations with academic and clinical partners, companies can translate laboratory breakthroughs into commercially viable solutions.

Second, reinforcing supply chain resilience through dual-sourcing strategies and localized manufacturing hubs will mitigate exposure to trade disruptions and tariff fluctuations. Such operational agility will enable rapid response to shifts in regional demand while maintaining cost discipline.

Third, expanding engagement with payers and regulatory bodies is essential to secure favorable reimbursement pathways, particularly for novel closure technologies that demonstrate clear value in reducing complication rates and shortening hospital stays. Pursuing value-based contracting models will underscore the total cost of care benefits of advanced products.

Lastly, forging targeted alliances with regional distributors and healthcare networks will facilitate market penetration in high-growth territories. Leveraging digital marketing and surgeon education programs can amplify adoption, ensuring that the latest advancements in staples, sutures and adhesives reach diverse clinical settings.

Robust Framework Guiding Comprehensive Market Intelligence

The methodological foundation of this analysis relies on a rigorous combination of primary and secondary research. Primary insights were obtained through structured interviews with key opinion leaders, including surgeons, procurement specialists and regulatory experts, who provided firsthand perspectives on clinical trends, purchasing drivers and unmet needs.

Secondary research encompassed exhaustive reviews of scientific literature, regulatory filings, patent databases and industry reports. This body of evidence was augmented by proprietary databases tracking product approvals, pricing benchmarks and distribution networks. Data were triangulated through cross-verification, ensuring consistency and validity across multiple sources.

Segmentation criteria were applied to categorize the market by product type, end user, application, indication and wound classification. External validation was achieved through consensus workshops with domain experts, refining assumptions and identifying emerging developments. Quality control measures, including methodology audits and editorial review, were implemented to uphold analytical rigor and ensure the final report reflects the most accurate and current market intelligence available.

Synthesizing Key Findings into Actionable Perspectives

The collective analysis underscores several strategic themes that will define the future of surgical incision closure. Innovation in biomaterials and device design continues to elevate clinical performance, while digital integration promises new levels of procedural precision and adaptability. Simultaneously, trade policies and reimbursement landscapes are recalibrating cost structures, compelling stakeholders to rethink sourcing, manufacturing and contracting approaches.

Regional dynamics further highlight the necessity of tailored strategies that align with local regulatory standards, healthcare infrastructure and economic realities. Companies that skillfully balance global product platforms with region-specific adaptations will capture disproportionate share gains in emerging markets.

Ultimately, the convergence of technological advancement, operational resilience and stakeholder collaboration will drive sustainable growth. By adhering to the actionable recommendations outlined herein, organizations can position themselves at the forefront of an industry poised for continued transformation and expansion.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Hemostats
      • Absorbable Gelatin Sponges
      • Oxidized Regenerated Cellulose
      • Thrombin Based
    • Staples
      • Manual
      • Powered
    • Sutures
      • Absorbable
        • Poliglecaprone
        • Polydioxanone
        • Polyglycolic Acid
      • Non Absorbable
        • Nylon
        • Polypropylene
        • Silk
    • Tissue Adhesives
      • Cyanoacrylate Adhesives
      • Fibrin Sealants
      • Polyethylene Glycol Sealants
  • End User
    • Ambulatory Surgical Centers
    • Clinics
      • Multi Specialty
      • Single Specialty
    • Home Care
    • Hospitals
      • Private
      • Public
  • Application
    • External
    • Internal
  • Indication
    • Cardiovascular
    • General Surgery
    • Gynecology
    • Neurosurgery
    • Orthopedic
    • Pediatric
  • Wound Type
    • Clean
    • Clean Contaminated
    • Contaminated
    • Dirty
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Medtronic plc
  • 3M Company
  • B. Braun Melsungen AG
  • Smith & Nephew plc
  • Baxter International Inc.
  • Teleflex Incorporated
  • Integra LifeSciences Holdings Corporation
  • Coloplast A/S
  • Terumo Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Surgical Incision Closures Market, by Product Type
8.1. Introduction
8.2. Hemostats
8.2.1. Absorbable Gelatin Sponges
8.2.2. Oxidized Regenerated Cellulose
8.2.3. Thrombin Based
8.3. Staples
8.3.1. Manual
8.3.2. Powered
8.4. Sutures
8.4.1. Absorbable
8.4.1.1. Poliglecaprone
8.4.1.2. Polydioxanone
8.4.1.3. Polyglycolic Acid
8.4.2. Non Absorbable
8.4.2.1. Nylon
8.4.2.2. Polypropylene
8.4.2.3. Silk
8.5. Tissue Adhesives
8.5.1. Cyanoacrylate Adhesives
8.5.2. Fibrin Sealants
8.5.3. Polyethylene Glycol Sealants
9. Surgical Incision Closures Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Clinics
9.3.1. Multi Specialty
9.3.2. Single Specialty
9.4. Home Care
9.5. Hospitals
9.5.1. Private
9.5.2. Public
10. Surgical Incision Closures Market, by Application
10.1. Introduction
10.2. External
10.3. Internal
11. Surgical Incision Closures Market, by Indication
11.1. Introduction
11.2. Cardiovascular
11.3. General Surgery
11.4. Gynecology
11.5. Neurosurgery
11.6. Orthopedic
11.7. Pediatric
12. Surgical Incision Closures Market, by Wound Type
12.1. Introduction
12.2. Clean
12.3. Clean Contaminated
12.4. Contaminated
12.5. Dirty
13. Americas Surgical Incision Closures Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Surgical Incision Closures Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Surgical Incision Closures Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Medtronic plc
16.3.3. 3M Company
16.3.4. B. Braun Melsungen AG
16.3.5. Smith & Nephew plc
16.3.6. Baxter International Inc.
16.3.7. Teleflex Incorporated
16.3.8. Integra LifeSciences Holdings Corporation
16.3.9. Coloplast A/S
16.3.10. Terumo Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SURGICAL INCISION CLOSURES MARKET MULTI-CURRENCY
FIGURE 2. SURGICAL INCISION CLOSURES MARKET MULTI-LANGUAGE
FIGURE 3. SURGICAL INCISION CLOSURES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SURGICAL INCISION CLOSURES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SURGICAL INCISION CLOSURES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SURGICAL INCISION CLOSURES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES SURGICAL INCISION CLOSURES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 87. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 89. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 90. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 91. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 92. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 93. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 94. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 96. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 97. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 103. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 104. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 105. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 106. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 166. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 168. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 169. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 170. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 171. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 172. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 173. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 175. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 178. GERMANY SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 182. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 183. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 184. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 185. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 186. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 188. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 189. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. FRANCE SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 205. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 207. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 208. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 209. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 210. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 211. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 212. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 214. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 215. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 217. ITALY SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 218. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 220. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 221. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 222. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 223. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 224. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 225. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 227. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 228. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. SPAIN SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 254. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 256. SAUDI ARABIA SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 270. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 272. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 273. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 274. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 275. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 276. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 277. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 279. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 280. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 282. DENMARK SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 296. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 298. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 299. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 300. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 301. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 302. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 303. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 305. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 306. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 308. QATAR SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 309. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 311. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 312. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 313. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 314. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2030 (USD MILLION)
TABLE 315. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2030 (USD MILLION)
TABLE 316. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 318. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 319. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 321. FINLAND SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN SURGICAL I

Companies Mentioned

The companies profiled in this Surgical Incision Closures market report include:
  • Johnson & Johnson
  • Medtronic plc
  • 3M Company
  • B. Braun Melsungen AG
  • Smith & Nephew plc
  • Baxter International Inc.
  • Teleflex Incorporated
  • Integra LifeSciences Holdings Corporation
  • Coloplast A/S
  • Terumo Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 17.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 24.93 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Surgical Incision Closures - Global Strategic Business Report - Product Image

Surgical Incision Closures - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Surgical Site Infection Control Market by Product Type, End User, Application, Surgery Type - Global Forecast to 2030 - Product Image

Surgical Site Infection Control Market by Product Type, End User, Application, Surgery Type - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Ophthalmic Sutures Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Ophthalmic Sutures Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Wound Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Wound Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Hemostats and Tissue Sealants - Global Strategic Business Report - Product Image

Hemostats and Tissue Sealants - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From

About the Surgical Incision Closure Market

The Surgical Incision Closure market is a segment of the Wound Care industry. It involves the use of medical devices to close surgical incisions, such as sutures, staples, and tissue adhesives. These products are used to reduce the risk of infection and promote healing. They are also used to reduce scarring and improve cosmetic outcomes. The Surgical Incision Closure market is highly competitive, with a range of products available from different manufacturers. Companies in the market include 3M, Ethicon, Smith & Nephew, B. Braun, and Medtronic. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.